Market Overview

UPDATE: J.P. Morgan Downgrades Axiall on Multiple Challenges Ahead

Top Performing Industries For May 25, 2016
Westlake Chemical Reports Filing of Definitive Proxy Statement, Investor Presentation Related to Axial Annual Meeting

In a report published Wednesday, J.P. Morgan analyst Jeffrey J. Zekauskas downgraded the rating on Axiall Corp. (NYSE: AXLL) from Overweight to Neutral, and lowered the price target from $53.00 to $46.00.

In the report, J.P. Morgan noted, “We rate Axiall Corp Neutral. The acquisition of the PPG assets effectively integrates Axiall fully into its chlorine and caustic requirements and enlarges its export capabilities. PPG probably operated its chloralkali assets at suboptimal rates of utilization as it did not have the vertical integration that would enable it to find a home for both its chlorine and its caustic soda. The combined entity generates substantial free cash flow on a sustainable basis. We forecast about $650M of EBITDA for the combined entity in 2013 and $685M for 2014. The costs of integration and year-one working capital additions should mute AXLL's overall free cash flow to $170 million, or $2.55 per share, in 2013 representing 6% of the current share price. We forecast a free cash flow yield of 10.3% in 2014, or $4.30/share.”

Axiall Corp. closed on Tuesday at $41.86.

Latest Ratings for AXLL

Apr 2016CitigroupMaintainsNeutral
Apr 2016SunTrust Robinson HumphreyDowngradesBuyNeutral
Mar 2016Cowen & CompanyUpgradesMarket PerformOutperform

View More Analyst Ratings for AXLL
View the Latest Analyst Ratings

Posted-In: J.P. Morgan Jeffrey J. ZekauskasAnalyst Color Downgrades Analyst Ratings


Related Articles (AXLL)

View Comments and Join the Discussion!